| Outgoing Relation(s) |
| EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) is a EC 2.7.11.* (protein-serine/threonine kinase) inhibitor (CHEBI:76812) |
| Incoming Relation(s) |
| BI-2536 (CHEBI:49868) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| GSK461364 (CHEBI:91333) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| GW843682X (CHEBI:91334) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| HMN-214 (CHEBI:91440) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| LFM-A13 (CHEBI:183517) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| rigosertib (CHEBI:145417) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| rigosertib sodium (CHEBI:145421) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
| volasertib (CHEBI:231358) has role EC 2.7.11.21 (polo kinase) inhibitor (CHEBI:145425) |
